Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-06-10 2:57 pm Sale | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | Capital World Investors | 3,446,156 4.900% | -3,629,358 (-51.29%) | Filing History |
| 2022-06-10 08:41 am Sale | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | Capital International Investors | 1,569,985 2.200% | -3,534,516 (-69.24%) | Filing History |
| 2022-05-10 11:56 am Purchase | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | Capital World Investors | 7,075,514 10.000% | 897,505 (+14.53%) | Filing History |
| 2022-02-11 2:48 pm Purchase | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | Capital World Investors | 6,178,009 9.400% | 1,528,561 (+32.88%) | Filing History |
| 2022-02-11 11:19 am Sale | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | Capital International Investors | 5,104,501 7.800% | -948,967 (-15.68%) | Filing History |
| 2022-02-03 4:41 pm Purchase | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | BlackRock Inc. BLK | 4,635,280 7.100% | 1,110,329 (+31.50%) | Filing |
| 2021-02-16 6:04 pm Purchase | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | Capital International Investors | 6,053,468 10.100% | 6,053,468 (New Position) | Filing History |
| 2021-02-16 2:04 pm Purchase | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | Capital World Investors | 4,649,448 7.800% | 4,649,448 (New Position) | Filing History |
| 2021-02-02 3:13 pm Purchase | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | BlackRock Inc. BLK | 3,524,951 5.900% | 677,476 (+23.79%) | Filing |
| 2020-02-14 12:30 pm Sale | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | JANUS HENDERSON GROUP PLC JHG | 0 0.000% | -3,143,758 (Position Closed) | Filing History |
| 2020-02-10 3:03 pm Purchase | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | Capital International Investors | 6,995,035 12.200% | 2,827,559 (+67.85%) | Filing |
| 2020-02-10 2:19 pm Sale | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | BlackRock Inc. BLK | 2,847,475 4.990% | -70,866 (-2.43%) | Filing |
| 2020-02-10 12:42 pm Purchase | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | Capital International Investors | 4,167,476 7.900% | 4,167,476 (New Position) | Filing |
| 2020-02-07 08:45 am Purchase | 13G | Biohaven Pharmaceutical Holding Company Ltd. BHVN | BlackRock Inc. BLK | 2,918,341 5.600% | 427,821 (+17.18%) | Filing |